Advertisements


Alpine Immune Sciences: Digging Into A Recent Newcomer Onto The Immunotherapy Scene

Alpine Immune Sciences: Digging Into A Recent Newcomer Onto The Immunotherapy Scene.....»»

Category: topSource: seekingalphaOct 11th, 2018

Alpine Immune Sciences doses first subject in ALPN-101 Phase I clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2019

Biotechnology Value Fund reports 6.5% passive stake in Alpine Immune Sciences

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 28th, 2019

Alpine Immune Sciences Inc (ALPN) Executive Chairman and CEO Mitchell Gold Bought $1 million of ...

Related Stocks: ALPN,.....»»

Category: blogSource: gurufocusJan 23rd, 2019

Alpine Immune Sciences CEO buys 191K shares of common stock

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2019

Alpine Immune Sciences target lowered to $11 placement dilution at Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2019

Alpine Immune Sciences announces $25M private placement

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 16th, 2019

Alpine Immune Sciences" ALPN-101 active in GvHD, CTA by YE18, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 2nd, 2018

Alpine Immune Sciences management to meet with Oppenheimer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 13th, 2018

Alpine Immune Sciences initiated with an Overweight at Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 27th, 2018

Alpine Immune Sciences initiated with an Outperform at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2018

Alpine Immune Sciences hires Alder co-founder as president and operations chief

Alder Biopharmaceuticals, the the Puget Sound region's third-largest biotech, has lost two of its three founders in the last six and hired new leaders......»»

Category: topSource: bizjournalsAug 7th, 2018

Alpine Immune Sciences appoints Mark Litton as COO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 6th, 2018

Rounds Report: Alpine Immune Sciences Broke The Trend In A Down Market

Rounds Report: Alpine Immune Sciences Broke The Trend In A Down Market.....»»

Category: topSource: seekingalphaJul 18th, 2018

Alpine Immune Sciences started at outperform with $13 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 29th, 2018

Alpine Immune Sciences initiated with an Outperform at Oppenheimer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 28th, 2018

Alpine Immune Sciences: What The Q1 2018 Earnings Foretell?

Alpine Immune Sciences: What The Q1 2018 Earnings Foretell?.....»»

Category: topSource: seekingalphaJun 7th, 2018

Alpine Is A Buy Ahead Of Clinical Trials, Wedbush Says In Positive Initiation

Wedbush analysts see an attractive entry point for Alpine Immune Sciences Inc. (NASDAQ: ALPN), as the biotech's initial candidates will enter the clinic over the next year. Latest Ratings fo.....»»

Category: blogSource: benzingaMay 18th, 2018

Wedbush starts Alpine Immune Sciences with Outperform, $13 target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 18th, 2018

Alpine Immune Sciences initiated at outperform at Wedbush

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 18th, 2018

Alpine Immune Sciences initiated with an Outperform at Wedbush

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2018